Tag: Zydus Cadila

Zydus Cadila, an innovation-driven, global pharmaceutical company, announced that it has submitted the New Drug Application (NDA) to the Drug Controller General...

Drug firm Zydus Cadila on Saturday said it has received approval from the US health regulator to market Decitabine injection, used to treat certain types of...

Zydus Cadila said today that its US subsidiary, Zydus Pharmaceuticals (USA) Inc., has obtained provisional permission from the US Food and Drug Administration (USFDA) to comercialise Eluxadoline Tablets in 75 mg and 100 mg dosages (US RLD: VIBERZI Tablets). Irritable bowel syndrome with diarrhoea or IBS-D, is treated with Eluxadoline Tablets in adults.

Ahmedabad, India: Global pharmaceutical company Zydus Cadila has received final approval from the US Food and Drug Administration (USFDA) to market its glycopyrrolate injection,...

New Delhi: Zydus Cadila has agreed to bring down the price of its C-19 vaccine to Rs 265 a dose following persistent negotiations...

Zydus Cadila has received tentative approval from the US Food and Drugs Administration (USFDA) to market Adapalene and Benzoyl Peroxide Gel 0.3%/2.5%....

Zydus Cadila's C-19 vaccine may cost around Rs 300 per dose, people in the know told ET. As government inches closer to deciding the...

With talks underway between the central government and Zydus Cadila over the pricing of the C-19 vaccine ZyCov-D, the pharma company is...

The government yesterday said Zydus Cadila’s indigenously-developed needle-free C-19 vaccine ZyCoV-D will be introduced in the nationwide anti C-19 virus vaccination drive...

NEW DELHI: Drug firm Zydus Cadila said it has received approval from the US health regulator to market Apremilast tablets, used to...

All Indian children aged 12 or older will become eligible for C-19 vaccinations from next month, when drug maker Cadila Healthcare launches...

Zydus Cadila has received final approval from the USFDA to market Vortioxetine Tablets in the strengths of 5 mg, 10 mg, 20...

Zydus Cadila has received tentative approval from the US Food and Drug Administration (USFDA) to market Brexpiprazole tablets in the strength of...

Gujarat : Releasing the first commercial batch of COVAXIN manufactured in Ankleshwar, a manufacturing capacity of more than 1 crore C-19 doses per month...

Zydus Cadila has received final approval from the US Food and Drug Administration (USFDA) to market tofacitinib extended release tablets, 11 mg...

Zydus Cadila has received final approval from the US Food and Drug Administration (USFDA) to market mesalamine extended-release capsules in the strength...

Zydus Cadila has received the final approval from the US Food and Drug Administration (USFDA) to market Fulvestrant injection, 250 mg/5 mL...

The Central Drugs Standard Control Organisation (CDSCO) has granted manufacturing permission to private manufacturers for three corona virus vaccines for restricted use...

Zydus Cadila has received final approval from US Food and Drug Administration (USFDA) to market emtricitabine and tenofovir disoproxil fumarate tablets, 100...

Zydus Cadila has received tentative approval from the USFDA to market Pemetrexed for Injection in the strengths of 100mg/vial, 500 mg/vial, and...

Zydus Cadila has received tentative approval from the United States US (USFDA) to market Fingolimod capsules in the strength of 0.25 mg...

Zydus Cadila has received tentative approval from the USFDA to market Brivaracetam Tablets, in the strengths of 10 mg, 25 mg, 50...

New Delhi: The only Indian company Zydus Cadila which claims to have developed neutralising monoclonal antibodies (mAbs)-based cocktail for the treatment of C-19 has been given...

Zydus Cadila has received tentative approval from the USFDA to market Osimertinib Tablets in the strengths of 40 mg and 80 mg...